Table 1 Baseline characteristics of patients randomised to 'GP' and 'GNP' groups.
Treatment group | |||
|---|---|---|---|
GP N = 86 | GNP N = 89 | ||
Age yrs | Mean (SD) | 48.4(12.8)) | 50.2 (13.9) |
Gender | Male | 42 (49) | 44 (49) |
BMI kg/m2 | Mean (SD) | 27.5 (5.0) | 27.0 (5.8) |
Smoking status | Current | 23 (27) | 24 (27) |
Ex | 43 (50) | 42 (47) | |
Non | 19 (22) | 23 (26) | |
Unknown | 1 (1) | 0 (0) | |
Alcohol | Drinker | 76(88) | 78 (88) |
Education (grouping) | |||
No qualifications | 30 (35) | 35 (39) | |
'O' levels & vocational qualifications | 22 (26) | 20 (22) | |
'A' levels to diplomas | 11 (13) | 12 (13) | |
Professional, 1st & higher degrees | 23 (27) | 22 (25) | |
Gladys score | Mean (SD) | 10.0 (3.0) | 9.9 (3.2) |
SF12 | Mean (SD) | 672.0 (157.3) | 627.7 (197.930) |
UHD costs (based on following*) | Mean (SD) in £ | 52.4(47.6) | 59.5(46.3) |
*UHD types in previous 6 months | Months of use | ||
Full dose PPI | 1.4(2.0) | 1.5(2.0) | |
Half dose PPI or H2RA | 1.1(1.9) | 1.5(2.2) | |
None | 3.4(2.2) | 3.0(2.2) | |